Loading cancer entity…
Loading cancer entity…
Clinical trials
79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02633553 | Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection | recruiting | N/A | 238 | Fudan UniversityOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT06692062 | Hypofractionated Radiotherapy for Thymic Epithelial Tumors | recruiting | N/A | 100 | Rongrong ZhouOTHER | 1 | Nov 18, 2024 | clinicaltrials |
| NCT06029621 |
| recruiting |
| N/A |
| 304 |
| Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER |
| 1 |
| Feb 29, 2024 |
| clinicaltrials |
Data updated 22 days agoSource updated Apr 24, 2026source: clinicaltrials